Acadia's third-quarter earnings and revenues top forecasts as Nuplazid and Daybue sales power double-digit annual growth.
HealthPartners made its third request in a decade to expand the trauma center, even as other hospitals contract.
Stockhead on MSN
Scott Power: ASX health sector dips, CSL steadies, Imricor delivers jolt of good news
The ASX healthcare sector fell for the week ending November 7, 2025, but several names have bucked the trend on positive news ...
“The colors were so sad,” Spera said. “So many leaves seemed like they had fallen prematurely.” ...
Good day, and thank you for standing by. Welcome to the Q3 2025 Great Lakes Dredge & Dock Corp Earnings Conference Call.
A viral video shared by Jasmine Saul shows the “catastrophe of a street” she lives. Shared through social media, the Ring ...
Guardant Health, Inc. , a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based screening test ...
“The colors were so sad,” Spera said. “So many leaves seemed like they had fallen prematurely.” ...
The federal shutdown spurred by political gridlock in Washington D.C. has halted federal food stamp benefits. The effects ...
Discover key Q3 2025 earnings insights for Great Lakes Dredge & Dock—record EBITDA outlook, robust backlog, and strong cash flow.
A viral video shared by Jasmine Saul shows the “catastrophe of a street” she lives. Shared through social media, the Ring ...
Zacks Investment Research on MSN
Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y
Nektar Therapeutics NKTR reported a loss of $1.87 per share for the third quarter of 2025, narrower than the Zacks Consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback